GB1426061A - Polypeptides - Google Patents
PolypeptidesInfo
- Publication number
- GB1426061A GB1426061A GB438773*[A GB438773A GB1426061A GB 1426061 A GB1426061 A GB 1426061A GB 438773 A GB438773 A GB 438773A GB 1426061 A GB1426061 A GB 1426061A
- Authority
- GB
- United Kingdom
- Prior art keywords
- insulin
- lys
- ala
- protease
- des
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 3
- 102000004877 Insulin Human genes 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 101001011741 Bos taurus Insulin Proteins 0.000 abstract 1
- 102000005593 Endopeptidases Human genes 0.000 abstract 1
- 108010059378 Endopeptidases Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- QOOWRKBDDXQRHC-BQBZGAKWSA-N L-lysyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN QOOWRKBDDXQRHC-BQBZGAKWSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 241001544324 Myxobacter Species 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 108010005991 Pork Regular Insulin Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 101710180316 Protease 2 Proteins 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 229920005654 Sephadex Polymers 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- IXIBAKNTJSCKJM-BUBXBXGNSA-N bovine insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 IXIBAKNTJSCKJM-BUBXBXGNSA-N 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 239000004026 insulin derivative Substances 0.000 abstract 1
- 230000002608 insulinlike Effects 0.000 abstract 1
- 239000002808 molecular sieve Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920002401 polyacrylamide Polymers 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB438773*[A GB1426061A (en) | 1972-12-28 | 1973-01-29 | Polypeptides |
IE2122/73A IE38539B1 (en) | 1972-12-28 | 1973-11-22 | Polypeptides |
CA186,556A CA1009974A (en) | 1972-12-28 | 1973-11-23 | Des-lys29-ala30-insulin and production thereof |
AU62979/73A AU474971B2 (en) | 1972-12-28 | 1973-11-28 | Polypeptides |
US420573A US3903069A (en) | 1972-12-28 | 1973-11-30 | Polypeptides obtained by modification of porcine or bovine insulin |
IL43751A IL43751A (en) | 1972-12-28 | 1973-12-04 | Des-lys29-ala30-insulins and their preparation |
CH1759373A CH599927A5 (sl) | 1972-12-28 | 1973-12-14 | |
NL7317159A NL7317159A (sl) | 1972-12-28 | 1973-12-14 | |
PL1973167350A PL91158B1 (sl) | 1972-12-28 | 1973-12-15 | |
SE7317256A SE404600B (sv) | 1972-12-28 | 1973-12-20 | Sett att framstella des-(lys29-ala30)-porcin-insulin och des-(lys29-ala30)-bovin-insulin |
DD175618A DD110490A5 (sl) | 1972-12-28 | 1973-12-21 | |
JP744631A JPS5726760B2 (sl) | 1972-12-28 | 1973-12-26 | |
FR7346550A FR2212136B1 (sl) | 1972-12-28 | 1973-12-27 | |
AT1084473A AT348152B (de) | 1972-12-28 | 1973-12-27 | Verfahren zur herstellung von neuen polypeptiden |
LU69075A LU69075A1 (sl) | 1972-12-28 | 1973-12-27 | |
HUIE605A HU170437B (sl) | 1972-12-28 | 1973-12-28 | |
ES421864A ES421864A1 (es) | 1972-12-28 | 1973-12-28 | Procedimiento para preparar insulinas des-lis29-ala30-por- cina y bovina. |
DE2364883A DE2364883C2 (de) | 1972-12-28 | 1973-12-28 | Des-Lys↑2↑↑9↑-Ala↑3↑↑0↑-Schweine- und -Rinderinsulin, Verfahren zu deren Herstellung und diese Insuline enthaltende injizierbare Präparate |
US05/573,027 US3989821A (en) | 1972-12-18 | 1975-04-30 | Polypeptides |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5974272 | 1972-12-28 | ||
GB438773*[A GB1426061A (en) | 1972-12-28 | 1973-01-29 | Polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1426061A true GB1426061A (en) | 1976-02-25 |
Family
ID=26239087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB438773*[A Expired GB1426061A (en) | 1972-12-18 | 1973-01-29 | Polypeptides |
Country Status (18)
Country | Link |
---|---|
US (1) | US3903069A (sl) |
JP (1) | JPS5726760B2 (sl) |
AT (1) | AT348152B (sl) |
AU (1) | AU474971B2 (sl) |
CA (1) | CA1009974A (sl) |
CH (1) | CH599927A5 (sl) |
DD (1) | DD110490A5 (sl) |
DE (1) | DE2364883C2 (sl) |
ES (1) | ES421864A1 (sl) |
FR (1) | FR2212136B1 (sl) |
GB (1) | GB1426061A (sl) |
HU (1) | HU170437B (sl) |
IE (1) | IE38539B1 (sl) |
IL (1) | IL43751A (sl) |
LU (1) | LU69075A1 (sl) |
NL (1) | NL7317159A (sl) |
PL (1) | PL91158B1 (sl) |
SE (1) | SE404600B (sl) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983002772A1 (en) * | 1982-02-08 | 1983-08-18 | Robin Ewart Offord | An improved method for preparing human insulin from non-human insulin |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO153061C (no) * | 1979-04-13 | 1986-01-08 | Shionogi & Co | Fremgangsmaate for fremstilling av et b30-threonininsulin |
JPS55138391A (en) * | 1979-04-13 | 1980-10-29 | Shionogi & Co Ltd | New synthetic method of peptide derivative |
DE3209184A1 (de) * | 1982-03-13 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen |
GB8610551D0 (en) * | 1986-04-30 | 1986-06-04 | Hoffmann La Roche | Polypeptide & protein derivatives |
US6673347B1 (en) | 1986-04-30 | 2004-01-06 | Gryphon Therapeutics | Polypeptide and protein derivatives and process for their preparation |
PH23446A (en) * | 1986-10-20 | 1989-08-07 | Novo Industri As | Peptide preparations |
AU641631B2 (en) * | 1988-12-23 | 1993-09-30 | Novo Nordisk A/S | Human insulin analogues |
US5716927A (en) * | 1988-12-23 | 1998-02-10 | Novo Nordisk A/S | Insulin analogs having a modified B-chain |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH471220A (de) * | 1964-05-09 | 1969-04-15 | Roehm & Haas Gmbh | Verfahren zur Herstellung einer L-Leucinamid, Hypertensin und Oxytocin spaltenden Aminopeptidase |
-
1973
- 1973-01-29 GB GB438773*[A patent/GB1426061A/en not_active Expired
- 1973-11-22 IE IE2122/73A patent/IE38539B1/xx unknown
- 1973-11-23 CA CA186,556A patent/CA1009974A/en not_active Expired
- 1973-11-28 AU AU62979/73A patent/AU474971B2/en not_active Expired
- 1973-11-30 US US420573A patent/US3903069A/en not_active Expired - Lifetime
- 1973-12-04 IL IL43751A patent/IL43751A/en unknown
- 1973-12-14 CH CH1759373A patent/CH599927A5/xx not_active IP Right Cessation
- 1973-12-14 NL NL7317159A patent/NL7317159A/xx unknown
- 1973-12-15 PL PL1973167350A patent/PL91158B1/pl unknown
- 1973-12-20 SE SE7317256A patent/SE404600B/xx unknown
- 1973-12-21 DD DD175618A patent/DD110490A5/xx unknown
- 1973-12-26 JP JP744631A patent/JPS5726760B2/ja not_active Expired
- 1973-12-27 LU LU69075A patent/LU69075A1/xx unknown
- 1973-12-27 AT AT1084473A patent/AT348152B/de not_active IP Right Cessation
- 1973-12-27 FR FR7346550A patent/FR2212136B1/fr not_active Expired
- 1973-12-28 HU HUIE605A patent/HU170437B/hu unknown
- 1973-12-28 ES ES421864A patent/ES421864A1/es not_active Expired
- 1973-12-28 DE DE2364883A patent/DE2364883C2/de not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983002772A1 (en) * | 1982-02-08 | 1983-08-18 | Robin Ewart Offord | An improved method for preparing human insulin from non-human insulin |
EP0087238A1 (en) * | 1982-02-08 | 1983-08-31 | Biogen N.V. | Am improved method for preparing human insulin from non-human insulin |
Also Published As
Publication number | Publication date |
---|---|
JPS4994698A (sl) | 1974-09-09 |
CA1009974A (en) | 1977-05-10 |
IE38539B1 (en) | 1978-04-12 |
IL43751A0 (en) | 1974-03-14 |
CH599927A5 (sl) | 1978-06-15 |
DE2364883A1 (de) | 1974-07-04 |
SE404600B (sv) | 1978-10-16 |
HU170437B (sl) | 1977-06-28 |
ES421864A1 (es) | 1976-08-01 |
NL7317159A (sl) | 1974-07-02 |
FR2212136A1 (sl) | 1974-07-26 |
AU6297973A (en) | 1975-05-29 |
IE38539L (en) | 1974-06-28 |
LU69075A1 (sl) | 1974-03-07 |
US3903069A (en) | 1975-09-02 |
PL91158B1 (sl) | 1977-02-28 |
DE2364883C2 (de) | 1984-07-19 |
IL43751A (en) | 1977-01-31 |
ATA1084473A (de) | 1978-06-15 |
FR2212136B1 (sl) | 1978-01-06 |
JPS5726760B2 (sl) | 1982-06-07 |
AT348152B (de) | 1979-02-12 |
DD110490A5 (sl) | 1974-12-20 |
AU474971B2 (en) | 1976-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2124685T3 (es) | Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso. | |
CA2032153A1 (fr) | Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant | |
NL194828B (nl) | Somatostatinepeptiden, alsmede dergelijke somatostatinepeptiden bevattende farmaceutische preparaten. | |
RU93046317A (ru) | Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции | |
CA1267496C (en) | PURIFICATION AND ACTIVATION OF INSOLUBLE INCLUSION BODY PROTEINS | |
DE69016655D1 (de) | Biologisch aktive polypeptide, die auf transformierten wachstumsfaktor-beta-sequenzen basieren. | |
IS2070B (is) | Stöðugar interferónlyfjablöndur á vökvaformi | |
GR1000083B (el) | Μυκητοβακτηριακα προιοντα εξ ανασυνθεσεως και πεπτιδια. | |
ES427365A1 (es) | Un metodo de aislamiento de uno al menos de los factores decoagulacion de la sangre: fibrinogeno, factor viii antihe- mofilia y factor b. | |
CA2094027A1 (en) | Osteogenic peptides | |
GB1426061A (en) | Polypeptides | |
NO177716C (no) | Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff | |
ATE144535T1 (de) | Plättchen blockierende peptide | |
IL79972A (en) | Protein recovery from inclusion bodies produced in transformant microorganisms | |
KR930013115A (ko) | Dna 분자 및 숙주 | |
ES8704511A1 (es) | Procedimiento para sintetizar peptidos a partir de aminoaci-dos | |
AU3629389A (en) | Novel peptides suppressing the function of the immune system, pharmaceutical compositions containing them and process for preparing same | |
HUT44609A (en) | Process for preparing new polypeptides | |
KR890008166A (ko) | 융합 단백질의 선택적 분해 방법 | |
ES418158A1 (es) | Un procedimiento de preparacion de nuevos peptidos. | |
CA2171953A1 (en) | Modified truncated complement system regulators | |
EP0490383A3 (en) | Peptides of the hiv-gag protein, their preparation and use | |
AU7378087A (en) | Interleukin-2 induced antineoplastic peptide | |
US3651231A (en) | Process for preparing lactogenic factor | |
GB1320298A (en) | Peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |